The DNA Methyltransferase Inhibitor 5-Aza-4'-thio-2'-Deoxycytidine Induces C>G Transversions and Acute Lymphoid

Ryan M Bertoli1, Yang Jo Chung1, Michael J Difilippantonio2

  • 1Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Cancer Research
|June 4, 2024
PubMed
Summary

DNA methyltransferase inhibitors (DNMTi) like Aza-TdCyd (ATC) can cause lymphoid leukemia by inducing C>G mutations. Deleting the Dck enzyme blocks this mutagenic effect, highlighting risks of DNMTi therapy.